@article{e6c3372975ea4f6aad9f168dcca10f81,
title = "Kidney-resident macrophages promote a proangiogenic environment in the normal and chronically ischemic mouse kidney",
abstract = "Renal artery stenosis (RAS) caused by narrowing of arteries is characterized by microvascular damage. Macrophages are implicated in repair and injury, but the specific populations responsible for these divergent roles have not been identified. Here, we characterized murine kidney F4/80+CD64+ macrophages in three transcriptionally unique populations. Using fate-mapping and parabiosis studies, we demonstrate that CD11b/cint are long-lived kidney-resident (KRM) while CD11chiMϕ, CD11cloMϕ are monocyte-derived macrophages. In a murine model of RAS, KRM self-renewed, while CD11chiMϕ and CD11cloMϕ increased significantly, which was associated with loss of peritubular capillaries. Replacing the native KRM with monocyte-derived KRM using liposomal clodronate and bone marrow transplantation followed by RAS, amplified loss of peritubular capillaries. To further elucidate the nature of interactions between KRM and peritubular endothelial cells, we performed RNA-sequencing on flow-sorted macrophages from Sham and RAS kidneys. KRM showed a prominent activation pattern in RAS with significant enrichment in reparative pathways, like angiogenesis and wound healing. In culture, KRM increased proliferation of renal peritubular endothelial cells implying direct pro-angiogenic properties. Human homologs of KRM identified as CD11bintCD11cintCD68+ increased in post-stenotic kidney biopsies from RAS patients compared to healthy human kidneys, and inversely correlated to kidney function. Thus, KRM may play protective roles in stenotic kidney injury through expansion and upregulation of pro-angiogenic pathways.",
author = "Puranik, {Amrutesh S.} and Leaf, {Irina A.} and Jensen, {Mark A.} and Hedayat, {Ahmad F.} and Ahmad Saad and Kim, {Ki Wook} and Saadalla, {Abdulrahman M.} and Woollard, {John R.} and Sonu Kashyap and Textor, {Stephen C.} and Grande, {Joseph P.} and Amir Lerman and Simari, {Robert D.} and Randolph, {Gwendalyn J.} and Duffield, {Jeremy S.} and Lerman, {Lilach O.}",
note = "Funding Information: AP was supported during the study by the James Nutter Family & Maria Long Family Fellowship at the Mayo Clinic, and currently supported by the Colton Center for Auto-immunity at NYU Langone Health. We thank Daniel J. Tschumperlin, Ph.D., for murine embryonic fibroblasts, Tim Bushnell from Excyte-Expert Cytometry, and Mayo Clinic Flow Cytometry Core. We also thank Jenny Pattengill from the Histology Core Facility (Mayo Clinic Arizona) and the Mayo Clinic Pathology Research Core in Rochester, MN. We thank, Timothy Niewold, director of Colton Center for Autoimmunity at NYU. We thank Cynthia Loomis, Sanmugapriya Selvaraj and Branka Brukner Dabovic, at the NYU{\textquoteright}s, Experimental Pathology Research Core, which is partially supported by the Cancer Center Support Grant P30CA016087. The Core{\textquoteright}s Vectra3 multispectral imaging system was purchased through Shared Instrument grant (1S10ODO21747). We also thank Marianna Foos, Biogen Scientific Computing for her help with uploading the FASTQ files. This study was partly supported by Biogen and by NIH grant numbers: DK104273, HL123160, DK102325, and DK100081. Funding Information: Competing Interests: This work was partly funded by a research grant from Biogen. IL is a current Biogen employee, and JSD a former employee of Biogen (currently at Vertex Pharmaceuticals). Other author(s) have no competing interests. Publisher Copyright: {\textcopyright} 2018, The Author(s).",
year = "2018",
month = dec,
day = "1",
doi = "10.1038/s41598-018-31887-4",
language = "English (US)",
volume = "8",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",
}